Teva CEO: Company would have gone bankrupt without layoffs - Business - Haaretz.com
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
Teva Stops Production At US Plant After FDA Concerns: Report
The logo of Teva Pharmaceutical Industries is seen on a part of their building in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy
GSK's $235 million verdict revived against Teva, again | Reuters.com
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Teva Pharmaceuticals gets a coronavirus boost, but it won't last long - Business - Haaretz.com
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva Pharmaceutical Industries Ltd | Reuters
US Supreme Court sides with Teva in drug dispute
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
What's 'down' with Teva? - The Jerusalem Post
Teva buys Anda for $500 million - ISRAEL21c
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva shares tumble amid political battle, doubt from Moody's
Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly
Teva stock plummets 18% after rough quarter in US generic drug market
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down
Teva Pharmaceutical Industries Ltd | Reuters
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
